{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:14:34Z","timestamp":1792678474356,"version":"4.5.0"},"reference-count":35,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/J500082\/1"],"award-info":[{"award-number":["ES\/J500082\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disord Clin Pract"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The accessibility of Parkinson's disease medicines is limited across sub\u2010Saharan Africa, which can have negative health, social and financial consequences for people with Parkinson's disease and their families. However, there is a stark gap in the literature regarding the impact of poor access to medicines on individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The study objective was to understand the accessibility of Parkinson's disease medicines in Kenya from the perspective of people with Parkinson's disease, their caregivers and neurologists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In\u2010depth qualitative interviews were conducted with 55 people with Parkinson's disease, 23 caregivers and 8 neurologists to understand their experience regarding challenges with accessing Parkinson's disease medicines and the health, social and financial impact of poor availability and affordability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Medicines for Parkinson's disease were deemed to be largely unavailable and unaffordable across Kenya. People with Parkinson's disease, caregivers and neurologists expressed the financial burden caused by long\u2010term treatment in the absence of health insurance coverage. Further, barriers accessing medicines negatively impacted symptom control, social relations, and quality of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Access to Parkinson's disease medicines in Kenya is limited, with severe implications for symptom management and quality of life. People with Parkinson's disease should be able to access and afford the medicines they need to manage their condition.<\/jats:p><\/jats:sec>","DOI":"10.1002\/mdc3.14192","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T22:44:40Z","timestamp":1724280280000},"page":"1373-1378","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration"],"prefix":"10.1002","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-6250","authenticated-orcid":false,"given":"Natasha","family":"Fothergill\u2010Misbah","sequence":"first","affiliation":[{"name":"Population Health Sciences Institute Newcastle University  Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juzar","family":"Hooker","sequence":"additional","affiliation":[{"name":"Aga Khan University Hospital  Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Kwasa","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Nairobi  Nairobi Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Walker","sequence":"additional","affiliation":[{"name":"Population Health Sciences Institute Newcastle University  Newcastle upon Tyne UK"},{"name":"Northumbria Healthcare NHS Foundation Trust  Newcastle upon Tyne UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.1783"},{"key":"e_1_2_8_3_1","volume-title":"Parkinson Disease: a Public Health Approach","author":"World Health Organization","year":"2022"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13904"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114148"},{"key":"e_1_2_8_6_1","volume-title":"Atlas: Country Resources for Neurological Disorders","author":"World Health Organization (WHO)","year":"2017"},{"key":"e_1_2_8_7_1","volume-title":"Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022\u20132031","author":"World Health Organization","year":"2023"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15278-7"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-219"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.05.009"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/196150"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12682"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12294"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl172"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czs108"},{"key":"e_1_2_8_17_1","first-page":"S34","article-title":"Availability of Parkinson's disease medicines in Ghana: a national survey [abstract]","volume":"34","author":"Cham M","year":"2019","journal-title":"Mov Disord"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28669"},{"key":"e_1_2_8_19_1","volume-title":"Lived Experiences of Parkinson's Disease in Kenya: Sociality, Improvisation and Hope","author":"Fothergill\u2010Misbah N","year":"2020"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2021.1954227"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1020"},{"key":"e_1_2_8_22_1","volume-title":"Thematic Analysis: A Practical Guide","author":"Braun V","year":"2021"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-5988-y"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28293"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001809"},{"issue":"1","key":"e_1_2_8_26_1","first-page":"101","article-title":"Treatment of parkinsonian syndromes in developing countries","volume":"26","author":"Ogunniyi A","year":"1997","journal-title":"Afr J Med Med Sci"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8603-7-38"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302041"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/2333393616641825"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/maq.12002"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-023-00454-7"},{"key":"e_1_2_8_32_1","volume-title":"Kenya Essential Medicines List 2023","author":"Ministry of Health","year":"2023"},{"key":"e_1_2_8_33_1","volume-title":"Selection of Essential Medicines at the Country Level: Using the WHO Model List of Essential Medicines to Update a National Essential Medicines List","author":"World Health Organization","year":"2020"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/01410768231181263"},{"key":"e_1_2_8_35_1","unstructured":"World Health Organization. Improving access to medicines for neurological disorders. Geneva; 2024. Licence: CC BY\u2010NC\u2010SA 3.0 IGO."},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu195"}],"container-title":["Movement Disorders Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mdc3.14192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T13:29:25Z","timestamp":1760966965000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mdc3.14192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/mdc3.14192"],"URL":"https:\/\/doi.org\/10.1002\/mdc3.14192","archive":["Portico"],"relation":{},"ISSN":["2330-1619","2330-1619"],"issn-type":[{"value":"2330-1619","type":"print"},{"value":"2330-1619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"2024-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}